net dbt
asset place differenti consum hc offer
attend cvss analyst day new york citi first sinc late first sinc
aetna deal analyst day preview link outlin
potenti scenario long-term growth also want hear
would need continu augment busi model drive
increment valu still abl answer everi question face busi
least overcam shorter-term pessimist financi outlook also
provid number qualit detail combin entiti drive
sharehold valu drive increment cost out healthcar system
progress like take time invest also pars
numer headwind caus us reduc ep estim see
still see piec lt busi opportun underappreci current
valuat thu reiter buy rate lower price object
account lower estim ep
reduc estim headwinds/tim
maintain ep reduc ep
reduc ep think estim
reflect current headwind face busi time store reboot
delay share repurchas restart time one year later previou even
reduc estim stock still trade histor metric
ep follow analyst day key focu execut plan outlin
follow analyst day focu immedi turn track progress
long-term plan mileston look includ increment updat
pbm sell season particularli given notabl custom loss roll-out
healthhub/increment healthcar servic model new geographi
variou new servic creat part integr busi macro-
orient news around drug price includ pend rebat rule propos
congress like key compon cvs/group sentiment
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
one largest healthcar compani
unit state provid retail mail
specialti pharmaci dispens servic
pharmaci benefit upon complet
acquisit aetna would becom one
vertic integr publicli trade
healthcar compani base
buy rate driven transform
vertic integr aetna stabl free cash
flow appeal valuat think
compani deal aetna provid ampl short-
term long-term synergi opportun
provid clear way extract valu
retail franchis stabl free cash flow
three busi allow
compani gener outsiz return
equiti next year
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
larri merlo presid ceo
aetna committe care team help patient care continuum
knee surgeri care team came home help patient
retail locat provid access telehealth servic
creat valu transform consum health experi
challeng access care industri theme
theme includ empow healthcar consum migrat
sick care self care evolut person care evolv
well posit drive chang
lot healthcar data owner econom recognized/trust brand
interact american annual
us popul within three mile pharmaci
patient enrol text messag program receiv real-
time alert prescriptions/oth servic
enterpris prioriti acceler growth expect ebit
long-term area
posit initi result health hub store
store open houston earlier year
expand market end
locat end
synergi expect integr
beyond enterpris modern
ep low singl digit growth mid-singl digit growth
low doubl digit growth
acceler growth compani pay debt buy back
synergi year track higher end rang
synergi
enterpris modern addit synergi
addit cost associ program
share repurchas retain current dividend
expect target leverag rang hit
assum modest share repo
revenu low singl digit integr synergi tax rate
outpac industri growth government servic
expect margin get back mid-point target rang
hif add revenu oper incom tax
impact headwind earn
revenu msd oper incom high singl digit
prior period develop includ
larger benefit break-open gener
revenu low mid singl digit oper profit low
impact centene/new busi
revenu low mid singl digit oper incom
mid-singl digit
flow debt
leverag close mid low
expect pay end
expect cash annual
target ep growth low doubl digit
strategi acceler growth
legaci minuteclin low acuity/prevent patient
minuteclin primari care physician
minuteclin manag scope typic primari care
spent aetna
budget almost budget
talk maxim home therapi
includ commerci kidney diseas spend drug
leverag care manag help patient navig care continuum
bring home hemo-dialysi fda think bring
market
enhanc technolog infrastructur optim pharmaci suppli chain modern
enterpris
develop intellig engag platform
diabet strategi health person much differ sick
focu consum centric technolog
optim pharmaci suppli chain
futur gener launch strong declin dramat
futur opportun around drug includ expand complex gener single-
big year launch humira biosimilar humira
sale
high-cost therapi like gene therapi t-cell therapi benefit
innov contract patient popul small save
want creat lifetim valu client aetna
medicar busi updat aetna becom industri leader
strong membership growth sinc individu group pdp
serv member
grow improv star geograph expans convert
pdp
pilot hospit home program
take grow industri growth commit star
excel person care commun home
member among insur aso includ tanf chip
expect medicaid expenditur servic
manag care
provid care medicaid patient minuteclin
materi increas use minuteclin medicaid
educ market
matur highli penetr price sensit
enrol employ sponsor popul
expect commerci membership low singl digit
expect grow penetr ancillari busi
commerci flat declin expect continu
contract market level
launch highli person pharmacist consult
goal help pharmacist work close patient
suffer chronic condit
greater autom back end
rebat guarante diminish complet abat
client price remain long-term headwind
net new contract posit driver larg neg driver
return posit
gross new busi less carve-in
non-renew declin net new busi
health plan busi alreadi renew
member point sale rebat industri leader
patient specialti drug digit engag kept specialti
unit price growth industri averag
novologix solut help physician reduc medic cost allow
choos lowest cost option
total specialti spend oncolog
market share retail pharmaci
front store growth driven health beauti person care
grow ebit
innov front store
store remodel toward health well beauti
expand dose packag past six month compet directli
provid day deliveri prescript front store item
store leas come renew compani evalu store focu
product
reduc pharmaci inventori next year
new health servic chronic diseas manag like diabet
introduct health concierg dietician
exceed initi target minuteclin visit per day front store sale
net promot score higher store healthhub
four metropolitan area philadelphia atlanta tampa
health hub end year
believ compani shift store healthhub model
patient visit minuteclin primari care physician
retail oper profit expect go posit next year detail driver
improv
confid grow ebit low singl digit
signific product sg optim benefit red
invest compani made wage reoccur
gener better year
gener biosimilar come market fair
amount opportun
fair amount gener competitor
outlook outlook relat regulatori legisl
thing could neg impact
spread price rebat rule dir huge cost
associ
busi summer
growth larg driver aet compani think
driver go forward think geograph expans hif fee come
back competit dynam
geograph expans expect get year growth
come exist market compani get
competit market assum peer price hif
healthhub roll-out end mani replac
minuteclin today also oper profit much come directli
healthhub
inclus clinic start current clinic
healthhub room
minuteclin benefit
turn market healthhub
pharmaci servic need grow order meet guidanc
expect busi grow time
headwind rebat contract due sell
season compani lost client
compani doesnt expect continu
integr synergi opex benefit benefit would take ep
investor expect growth pbm busi
leverag monetization/synergi off-set
weak gener
primari beneficiari synergi healthcar benefit segment
price environ pharmaci side need chang pharmaci
footprint compani industri
take cost busi
open new store pacif select
fill-in opportun also close store
differenti aetna health plan member versu non-aetna
addit servic avail aetna member
fill houston market year
issu compani hear investor get wrong
mani thing expand tool capabl
compani hope present today help answer question
investor
compani look demograph econom overlap aetna
expand healthhub also view brand inflat much
flexibl meet goal brand inflat januari
densiti diseas aet book busi store specif
minuteclin alreadi
assum brand inflat mid-singl digit guidanc
factor impact reimburs pbm busi
custom want flexibl
pace cadenc deliv convers rate agenc
commit low leverag end remain
focus
lot opportun continu transpar
benefit floor
half save accru benefit busi
opportun optim valu across enterpris time
goe guidanc
contempl known still earli
pdp divestitur strand cost
repeat given typic guidanc
provid element formal guidanc like hif
script growth bake guidanc
dont anticip materi retail step-down base current
known inclus pbm loss grow script
noth uniqu busi mix lost pbm client close
half growth come medic adher
also posit network posit
lost pbm busi addit color
lost client issu uniqu channel
everi intent retain busi servic level high
healthhub store/cost impact transit
store remodel new thing done week
see increas front store sale despit shrink footprint
rx w/in healthhub bring net new peopl
havent done ton market yet healthhub
opportun product line add time dme cpap
off-set consum gener merchandis
healthhub best think today need that
base look deep next market expand
long-term view store base
industri over-box doesnt mean
close coupl hundr unprofit store act
like conveni store
look long horizon leas renew come
wide time period long leas last mani year
open stores/year still geograph void
view dialysi broadli
home princip plan lead better outcom
view commerci market
govern opportun signific optimist
reimburs pressur built pharmaci outlook
outlook unchang y-o-i level reimburs pressur
reimbursement/pr view bake pbm
dramat shift trend seen histor
typic abl off-set price cog
client ask cost-plu model guarante net
discuss w/client capit model
pharmaci ebit driver puts/tak
sometim custom mix creat margin put take
retail see minim synergi
omnicar get better y-o-i annual wrap tax invest
pharmaci market
start see grocer think differ pharmaci
like see contract market time size/scale/clin
stabil year help servic improv stabil
improv retent new busi win
assist live remain opportun
expect chang pharmaci network contract
start manag care network
goal improv pharmaci network servic levels/outcom
could see better reimburs share benefit better
new plan design offer manag care sell season
alreadi start cross-sel contract medic
pharmaci
see recept around capabl market
nation account want see healthhub nation
alreadi administr effici built-in given long-tim
look portfolio
complet review talk work done
timelin fda approv home dialysi
wait approv clinic trial
shorter cycl
target end
still feel posit stand
statu on-going opioid case
two store sanford fl complet caught guard
caus compani activ respond process
work hard identifi medic necess vs abus
stop fill rx doctor year
consist work take back medic
continu defend action done part
price object base ep estim previous
multipl five-year averag absolut basi lower
end histor rang also repres bigger discount
vs last five year discount reflect margin pressur across core
pharmaci servic retail pharmaci segment uncertainti around drug price
downsid risk po risk amazon anoth disrupt forc enter
suppli chain failur gener gener expect synergi aetna
transact regulatori issu relat post-clos activ grow
competit risk pharmaci benefit market includ competit price around
rebat on-going oper challeng long-term care pharmaci busi
slow prescription/insur trend upsid risk po potenti
prescript volum pickup faster stronger expect synergi aetna
improv front-end perform
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
